Congenital Heart Disease refers to structural abnormalities of the heart or major blood vessels that are present from birth, although their clinical manifestations may not become apparent until childhood or adulthood. Congenital abnormalities can affect the heart's chambers, valves, septa, great arteries, coronary anatomy or connections between cardiovascular structures. They range from relatively simple defects that cause few symptoms to complex conditions requiring multiple procedures and lifelong specialist care. The term describes an anatomical or developmental condition rather than a single disease. Some abnormalities primarily alter blood flow, while others cause cyanosis, pressure overload, volume overload or impaired cardiac function.
Congenital heart abnormalities arise during fetal cardiovascular development, which is a highly complex process involving formation and remodelling of cardiac chambers, valves, septa and major vessels. Causes are often multifactorial and may involve genetic factors, chromosomal abnormalities, maternal conditions, medications, infections or environmental influences, although in many individual cases no single cause can be established. Examples of structural patterns include holes between cardiac chambers, abnormalities of the great arteries, abnormal valves and complex combinations of defects. The presence of a congenital abnormality does not necessarily imply that it was inherited directly from a parent.
Congenital heart disease can be broadly described as acyanotic or cyanotic according to whether the defect typically causes significant mixing of oxygen-poor and oxygen-rich blood and therefore low systemic oxygenation. Septal defects can permit abnormal blood flow between chambers, while defects involving the great arteries can alter the route through which blood travels between the heart, lungs and systemic circulation. Some lesions initially produce increased pulmonary blood flow, while others reduce pulmonary flow or cause obstruction. The physiological consequences depend on the anatomy and pressure relationships rather than simply on the name of the defect.
Some Congenital Heart Disease is detected before birth through fetal imaging, while other abnormalities are identified shortly after delivery because of cyanosis, abnormal breathing, poor feeding, failure to thrive or a heart murmur. Newborn screening programmes using pulse oximetry can help identify certain serious defects that may not be obvious on physical examination alone. Echocardiography is central to anatomical and functional assessment. Additional imaging, cardiac catheterisation, ECG and other investigations can be used when detailed information about anatomy, pressures or circulation is required.
Treatment depends on the defect and its physiological consequences. Small defects may close spontaneously or require only monitoring, whereas significant abnormalities may require catheter-based procedures or surgery. Some congenital conditions are repaired during infancy because untreated circulation can threaten organ development or survival. Others are managed through staged procedures over several years. Treatment can sometimes restore near-normal circulation but does not necessarily remove every long-term consequence of the original anatomy. Even after successful repair, people may require lifelong surveillance because residual lesions, scar-related arrhythmias, valve problems or ventricular dysfunction can develop later.
Congenital Heart Disease has become increasingly relevant to adult healthcare because advances in paediatric diagnosis and treatment mean that many affected children survive into adulthood. Adults with congenital heart disease may have repaired, palliated or unrepaired anatomy and can develop complications including arrhythmias, heart failure, pulmonary hypertension, valve dysfunction and aortic abnormalities. Pregnancy can present additional cardiovascular demands and may require pre-pregnancy counselling and specialist monitoring depending on the lesion. The complexity of adult congenital care varies considerably, and patients with complex anatomy may benefit from specialist services familiar with their particular cardiovascular history.
Genetics plays an important but variable role. Certain congenital heart defects occur more frequently in people with particular chromosomal conditions or genetic syndromes, while some families have an increased recurrence risk of specific defects. Genetic counselling can help families understand known associations and the limitations of available testing. Environmental and maternal factors can also contribute to developmental risk, but identifying an association does not establish that a particular factor caused an individual child's condition. This distinction is important because congenital abnormalities frequently result from multiple interacting influences and may occur without any identifiable preventable cause.
Congenital Heart Disease is distinct from heart disease acquired later in life, although people with congenital abnormalities can subsequently develop acquired cardiovascular conditions. It is also distinct from genetic disease: a congenital defect is defined by presence at birth, whereas a genetic condition is defined by its relationship to genetic variation, and the two categories can overlap without being synonymous.
Modern care increasingly emphasises lifelong surveillance, physical activity appropriate to the individual's anatomy and physiology, psychosocial support, reproductive counselling and transition from paediatric to adult services. The long-term outlook varies enormously according to the specific anatomy, interventions received and residual physiological effects, so the term should never be interpreted as indicating a single predictable clinical course.
